Literature DB >> 8376577

Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.

T Matsui1, K Sano, T Tsukamoto, M Ito, T Takaishi, H Nakata, H Nakamura, K Chihara.   

Abstract

Both platelet-derived growth factor (PDGF) A- and B-chains are expressed in mammalian neurons, but their precise roles still remain to be clarified. In the present studies, we examined the expression of two PDGF receptor genes in human tumor cell lines derived from neural crest. The expression of alpha and/or beta PDGF receptors was detected in a wide variety of neural crest-derived human tumor cell lines such as neuroblastoma, primitive neuroectodermal tumor, and Ewing's sarcoma by RNA blot analysis, and confirmed by immunoblot analysis. We have also demonstrated that PDGF receptors on the human neuroblastoma cell lines were biologically functional. Accordingly, chemotactic and mitogenic activities were induced by either PDGF-AA or PDGF-BB in serum-free medium. PDGF isoforms as well as nerve growth factor induced morphological changes showing neuronal cell maturation. Moreover, PDGF coordinately increased the levels of the transcript of the midsize neurofilament gene. The neuroblastoma cell lines also expressed the transcripts of PDGF A- and B-chains. These findings suggest that PDGF isoforms are involved not only in the promotion of the neuroblastoma cell growth, but also in neuronal cell migration, growth, and differentiation in human brain development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376577      PMCID: PMC288252          DOI: 10.1172/JCI116684

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency.

Authors:  T Miki; T Matsui; M A Heidaran; S A Aaronson
Journal:  Gene       Date:  1989-11-15       Impact factor: 3.688

2.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Structure and sequence of the human c-sis/platelet-derived growth factor 2 (SIS/PDGF2) transcriptional unit.

Authors:  C D Rao; H Igarashi; I M Chiu; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  Establishment and characterization of a human neuroblastoma cell line in tissue culture.

Authors:  M Sekiguchi; T Oota; K Sakakibara; N Inui; G Fujii
Journal:  Jpn J Exp Med       Date:  1979-02

5.  Developmentally regulated production of platelet-derived growth factor-like molecules.

Authors:  R A Seifert; S M Schwartz; D F Bowen-Pope
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

6.  Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors.

Authors:  J S Huang; S S Huang; T F Deuel
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

7.  Characterization of human neuroblastoma cell lines established before and after therapy.

Authors:  C P Reynolds; J L Biedler; B A Spengler; D A Reynolds; R A Ross; E P Frenkel; R G Smith
Journal:  J Natl Cancer Inst       Date:  1986-03       Impact factor: 13.506

8.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines.

Authors:  C Betsholtz; A Johnsson; C H Heldin; B Westermark; P Lind; M S Urdea; R Eddy; T B Shows; K Philpott; A L Mellor
Journal:  Nature       Date:  1986 Apr 24-30       Impact factor: 49.962

9.  Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells.

Authors:  W Spinelli; K H Sonnenfeld; D N Ishii
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

10.  Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines.

Authors:  F Gilbert; G Balaban; P Moorhead; D Bianchi; H Schlesinger
Journal:  Cancer Genet Cytogenet       Date:  1982-09
View more
  16 in total

Review 1.  Cell survival signaling in neuroblastoma.

Authors:  Michael L Megison; Lauren A Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

2.  p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy.

Authors:  Myrthala Moreno-Smith; Anna Lakoma; Zaowen Chen; Ling Tao; Kathleen A Scorsone; Linda Schild; Kevin Aviles-Padilla; Rana Nikzad; Yankai Zhang; Rikhia Chakraborty; Jan J Molenaar; Sanjeev A Vasudevan; Vivien Sheehan; Eugene S Kim; Silke Paust; Jason M Shohet; Eveline Barbieri
Journal:  Clin Cancer Res       Date:  2017-08-18       Impact factor: 12.531

3.  UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.

Authors:  Peter E Zage; Natalie Sirisaengtaksin; Yin Liu; Monica Gireud; Brandon S Brown; Shana Palla; Kristen N Richards; Dennis P M Hughes; Andrew J Bean
Journal:  Cancer       Date:  2012-09-18       Impact factor: 6.860

4.  Regulation of neuroblastoma differentiation by forkhead transcription factors FOXO1/3/4 through the receptor tyrosine kinase PDGFRA.

Authors:  Yang Mei; Zhanxiang Wang; Lei Zhang; Yiru Zhang; Xiaoyu Li; Huihui Liu; Jing Ye; Han You
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

Review 5.  More than the genes, the tumor microenvironment in neuroblastoma.

Authors:  Lucia Borriello; Robert C Seeger; Shahab Asgharzadeh; Yves A DeClerck
Journal:  Cancer Lett       Date:  2015-11-17       Impact factor: 8.679

6.  Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

Authors:  J Klominek; B Baskin; D Hauzenberger
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

7.  The novel kinase inhibitor EMD1214063 is effective against neuroblastoma.

Authors:  Kathy Scorsone; Linna Zhang; Sarah E Woodfield; John Hicks; Peter E Zage
Journal:  Invest New Drugs       Date:  2014-05-16       Impact factor: 3.850

8.  Chotosan (Diaoteng San)-induced improvement of cognitive deficits in senescence-accelerated mouse (SAMP8) involves the amelioration of angiogenic/neurotrophic factors and neuroplasticity systems in the brain.

Authors:  Qi Zhao; Takako Yokozawa; Koichi Tsuneyama; Ken Tanaka; Takeshi Miyata; Notoshi Shibahara; Kinzo Matsumoto
Journal:  Chin Med       Date:  2011-09-23       Impact factor: 5.455

9.  Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.

Authors:  Laura V Bownes; Adele P Williams; Raoud Marayati; Colin H Quinn; Sara C Hutchins; Jerry E Stewart; Trung Vu; Juliet L Easlick; Elizabeth Mroczek-Musulman; David K Crossman; Joshua C Anderson; Christopher D Willey; Pran K Datta; Elizabeth A Beierle
Journal:  Cancers (Basel)       Date:  2021-06-26       Impact factor: 6.639

10.  Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.

Authors:  Qi Zhao; Yimin Niu; Kinzo Matsumoto; Koichi Tsuneyama; Ken Tanaka; Takeshi Miyata; Takako Yokozawa
Journal:  BMC Complement Altern Med       Date:  2012-10-20       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.